Comparative Measures of Lean Body Tissues in the Clinical Setting

Panna A. Codner, Kristin Shields, Matthew Kappus, Bryan Collier, Martin Rosenthal, Robert Martindale

Research output: Contribution to journalReview article

Abstract

Age-related decreases in muscle mass and function, known as sarcopenia, have been shown to be related to functional limitation, frailty, and an increase in morbidity and mortality. While the most accurate method to assess muscle mass is biopsy, this is impractical clinically. There are numerous methods to assess skeletal muscle mass including dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) which are low cost and accessible. There are also more specific standards for assessing muscle mass or cross-sectional muscle area including magnetic resonance imaging (MRI) and computerized tomography (CT). Each method has its own advantages and limitations in clinical practice. Other emerging methods include peripheral quantitative CT and ultrasound. The ideal test would be valid and reliable, low cost, and practical combined with simple measurements of isometric strength to define sarcopenia and predict future health events.

Original languageEnglish (US)
Pages (from-to)191-198
Number of pages8
JournalCurrent Nutrition Reports
Volume5
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Body Weights and Measures
sarcopenia
Sarcopenia
Muscles
muscles
tomography
Tomography
Costs and Cost Analysis
dual-energy X-ray absorptiometry
bioelectrical impedance
Photon Absorptiometry
methodology
Electric Impedance
magnetic resonance imaging
morbidity
skeletal muscle
biopsy
Skeletal Muscle
Magnetic Resonance Imaging
Morbidity

Keywords

  • Bioelectrical impedance
  • Body composition
  • Body mass index
  • Computerized tomography
  • Critical illness
  • Cross-sectional imaging
  • DEXA
  • Frailty
  • Magnetic resonance imaging
  • Morbidity
  • Mortality
  • Outcomes
  • Sarcopenia
  • Ultrasound

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Comparative Measures of Lean Body Tissues in the Clinical Setting. / Codner, Panna A.; Shields, Kristin; Kappus, Matthew; Collier, Bryan; Rosenthal, Martin; Martindale, Robert.

In: Current Nutrition Reports, Vol. 5, No. 3, 01.09.2016, p. 191-198.

Research output: Contribution to journalReview article

Codner, PA, Shields, K, Kappus, M, Collier, B, Rosenthal, M & Martindale, R 2016, 'Comparative Measures of Lean Body Tissues in the Clinical Setting', Current Nutrition Reports, vol. 5, no. 3, pp. 191-198. https://doi.org/10.1007/s13668-016-0169-3
Codner, Panna A. ; Shields, Kristin ; Kappus, Matthew ; Collier, Bryan ; Rosenthal, Martin ; Martindale, Robert. / Comparative Measures of Lean Body Tissues in the Clinical Setting. In: Current Nutrition Reports. 2016 ; Vol. 5, No. 3. pp. 191-198.
@article{ea86bdbea4e042de8722f341f5081a06,
title = "Comparative Measures of Lean Body Tissues in the Clinical Setting",
abstract = "Age-related decreases in muscle mass and function, known as sarcopenia, have been shown to be related to functional limitation, frailty, and an increase in morbidity and mortality. While the most accurate method to assess muscle mass is biopsy, this is impractical clinically. There are numerous methods to assess skeletal muscle mass including dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) which are low cost and accessible. There are also more specific standards for assessing muscle mass or cross-sectional muscle area including magnetic resonance imaging (MRI) and computerized tomography (CT). Each method has its own advantages and limitations in clinical practice. Other emerging methods include peripheral quantitative CT and ultrasound. The ideal test would be valid and reliable, low cost, and practical combined with simple measurements of isometric strength to define sarcopenia and predict future health events.",
keywords = "Bioelectrical impedance, Body composition, Body mass index, Computerized tomography, Critical illness, Cross-sectional imaging, DEXA, Frailty, Magnetic resonance imaging, Morbidity, Mortality, Outcomes, Sarcopenia, Ultrasound",
author = "Codner, {Panna A.} and Kristin Shields and Matthew Kappus and Bryan Collier and Martin Rosenthal and Robert Martindale",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s13668-016-0169-3",
language = "English (US)",
volume = "5",
pages = "191--198",
journal = "Current Nutrition Reports",
issn = "2161-3311",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Comparative Measures of Lean Body Tissues in the Clinical Setting

AU - Codner, Panna A.

AU - Shields, Kristin

AU - Kappus, Matthew

AU - Collier, Bryan

AU - Rosenthal, Martin

AU - Martindale, Robert

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Age-related decreases in muscle mass and function, known as sarcopenia, have been shown to be related to functional limitation, frailty, and an increase in morbidity and mortality. While the most accurate method to assess muscle mass is biopsy, this is impractical clinically. There are numerous methods to assess skeletal muscle mass including dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) which are low cost and accessible. There are also more specific standards for assessing muscle mass or cross-sectional muscle area including magnetic resonance imaging (MRI) and computerized tomography (CT). Each method has its own advantages and limitations in clinical practice. Other emerging methods include peripheral quantitative CT and ultrasound. The ideal test would be valid and reliable, low cost, and practical combined with simple measurements of isometric strength to define sarcopenia and predict future health events.

AB - Age-related decreases in muscle mass and function, known as sarcopenia, have been shown to be related to functional limitation, frailty, and an increase in morbidity and mortality. While the most accurate method to assess muscle mass is biopsy, this is impractical clinically. There are numerous methods to assess skeletal muscle mass including dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) which are low cost and accessible. There are also more specific standards for assessing muscle mass or cross-sectional muscle area including magnetic resonance imaging (MRI) and computerized tomography (CT). Each method has its own advantages and limitations in clinical practice. Other emerging methods include peripheral quantitative CT and ultrasound. The ideal test would be valid and reliable, low cost, and practical combined with simple measurements of isometric strength to define sarcopenia and predict future health events.

KW - Bioelectrical impedance

KW - Body composition

KW - Body mass index

KW - Computerized tomography

KW - Critical illness

KW - Cross-sectional imaging

KW - DEXA

KW - Frailty

KW - Magnetic resonance imaging

KW - Morbidity

KW - Mortality

KW - Outcomes

KW - Sarcopenia

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=85057643971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057643971&partnerID=8YFLogxK

U2 - 10.1007/s13668-016-0169-3

DO - 10.1007/s13668-016-0169-3

M3 - Review article

VL - 5

SP - 191

EP - 198

JO - Current Nutrition Reports

JF - Current Nutrition Reports

SN - 2161-3311

IS - 3

ER -